23,682 Shares in Marsh & McLennan Companies, Inc. $MRSH Bought by Keybank National Association OH

Keybank National Association OH purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) in the first quarter, HoldingsChannel reports. The institutional investor purchased 23,682 shares of the financial services provider’s stock, valued at approximately $4,108,000.

Several other institutional investors also recently modified their holdings of the company. Numerai GP LLC raised its stake in Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after acquiring an additional 33,729 shares during the period. Swiss Life Asset Management Ltd increased its holdings in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after purchasing an additional 11,648 shares during the last quarter. Sarasin & Partners LLP raised its position in shares of Marsh & McLennan Companies by 0.9% in the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after purchasing an additional 8,283 shares during the period. CSM Advisors LLC acquired a new stake in shares of Marsh & McLennan Companies during the 3rd quarter worth about $1,180,000. Finally, Brown Brothers Harriman & Co. boosted its holdings in shares of Marsh & McLennan Companies by 26.4% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock worth $27,444,000 after buying an additional 28,419 shares during the period. 87.99% of the stock is currently owned by institutional investors and hedge funds.

Marsh & McLennan Companies Stock Down 0.2%

Shares of MRSH opened at $178.13 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $216.32. The company has a market cap of $86.05 billion, a PE ratio of 22.27, a price-to-earnings-growth ratio of 2.60 and a beta of 0.61.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last issued its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion during the quarter. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.

Insider Buying and Selling at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Analysts Set New Price Targets

MRSH has been the topic of several research analyst reports. JPMorgan Chase & Co. lowered their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a report on Thursday, April 9th. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, May 6th. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Piper Sandler reduced their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Finally, Morgan Stanley decreased their price objective on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $200.19.

Get Our Latest Stock Analysis on MRSH

About Marsh & McLennan Companies

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

See Also

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.